Ambulatory blood pressure measurement in the renal patient

被引:21
作者
Covic, A [1 ]
Goldsmith, DJA [1 ]
机构
[1] Parhon Hosp, Iasi 6600, Romania
关键词
D O I
10.1007/s11906-002-0066-6
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Ambulatory blood pressure monitoring has been steadily growing in popularity as equipment becomes more accurate, affordable, and patient friendly. In addition, software packages are more powerful and physician-customizable and more physicians are accepting of ambulatory blood pressure monitoring's advantages. Summarizing the studies that deal mainly with hemodialysis patients, there are clear advantages to using more than isolated pre- and postemodialysis blood pressure readings. If enough predialysis blood pressure readings are taken and average, this is a reasonable guide to end-organ damage (ie. left ventricular hypertrophy), Home and ambulatory blood pressure-derived values are complementary, and only this approach can discern any further contribution from diurnal blood pressure elevation. The cross-sectional association between blood pressure and end-organ damage is very week in end-stage renal disease patients if the blood pressure values are "casual", but the relationship is much stronger when ambulatory blood pressure monitoring-derived measurements are used. One prospective study clearly linked the sustained loss of diurnal blood pressure fall with sleep with progressive left ventricular dilatation. Loss of circadian variation in blood pressure is associated with an increased mortality rate for dialysis patients and for diabetic patients, regardless of diabetes type. The combination of nondipping in renal impairment leads to a high mortality rate. Much more work is needed to dissect out the causes for abnormal diurnal blood pressure rhythm and attempt to modulate this parameter. Obstructive sleep apnea may be a promising target for intervention.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 33 条
[2]   Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients [J].
Amar, J ;
Vernier, I ;
Rossignol, E ;
Bongard, V ;
Arnaud, C ;
Conte, JJ ;
Salvador, M ;
Chamontin, B .
KIDNEY INTERNATIONAL, 2000, 57 (06) :2485-2491
[3]   Association between Albumin:Creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension [J].
Boulatov, VA ;
Stenehjem, A ;
Os, I .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (04) :338-344
[4]   Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients [J].
Cannella, G ;
Paoletti, E ;
Ravera, G ;
Cassottana, P ;
Araghi, P ;
Mulas, D ;
Peloso, G ;
Delfino, R ;
Messa, P .
KIDNEY INTERNATIONAL, 2000, 58 (01) :260-268
[5]   SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
CONVERSE, RL ;
JACOBSEN, TN ;
TOTO, RD ;
JOST, CMT ;
COSENTINO, F ;
FOUADTARAZI, F ;
VICTOR, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1912-1918
[6]  
Covic A, 1999, J NEPHROL, V12, P220
[7]   Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients [J].
Covic, A ;
Goldsmith, DJA ;
Covic, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :617-623
[8]   Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy [J].
Csiky, B ;
Kovács, T ;
Wágner, L ;
Vass, T ;
Nagy, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) :86-90
[9]  
CUSPIDI C, J HYPERTENS, V19, P1539
[10]  
de la Sierra A, 2000, BRIT J BIOMED SCI, V57, P287